Does Intermittent Fasting Work?

| February 2, 2019

article image
One of the biggest diet and nutrition trends these days is intermittent fasting. Every week, I hear from listeners wanting to know my thoughts on it. I've mentioned intermittent fasting on the podcast before, in an episode on the health benefits of fasting. But that was way back in 2011. At that point, the research was still quite preliminary and most of it had been done in rodents.

Spotlight

US Radiology Specialists

Founded jointly in April 2018 by Charlotte Radiology, one of the nation's largest private radiology groups, and Welsh, Carson, Anderson & Stowe, a leading healthcare investment firm, US Radiology Specialists provides partners with the resources they need to thrive in the rapidly evolving healthcare arena. Each physician group maintains clinical control of their practice, backed by strong financial and operational support from some of healthcare's best and brightest business minds.

OTHER ARTICLES

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

Top Pharmaceutical Firms Urge FDA to Adopt Blockchain for Drug Tracking

Article | April 1, 2020

Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following the successful completion of a DLT pilot project with the Food and Drug Administration (FDA), according to reports on February 24, 2020. Though nascent, blockchain technology, the building blocks of Bitcoin (BTC) and other cryptocurrencies are fast gaining ground across various ecosystems, due to its immutability, security, privacy, and other intricate properties. In the latest development, 25 leading manufacturers of pharmaceutical products, logistics partners and other market participants in the pharma supply chain, have published a report that highlights the importance of blockchain technology in drug traceability.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | April 1, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Pricing of drugs – at what cost?

Article | April 1, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

Spotlight

US Radiology Specialists

Founded jointly in April 2018 by Charlotte Radiology, one of the nation's largest private radiology groups, and Welsh, Carson, Anderson & Stowe, a leading healthcare investment firm, US Radiology Specialists provides partners with the resources they need to thrive in the rapidly evolving healthcare arena. Each physician group maintains clinical control of their practice, backed by strong financial and operational support from some of healthcare's best and brightest business minds.

Events